MARKET WIRE NEWS

Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript

Source: SeekingAlpha

2026-02-25 07:31:36 ET

Novozymes A/S (NVZMY) Q4 2025 Earnings Call February 25, 2026 3:00 AM EST

Company Participants

Tobias Björklund - Head of Investor Relations
Ester Baiget - President & CEO
Rainer Lehmann - Executive VP & CFO
Henrik Nielsen - EVP of Human Health Biosolutions and Strategy & Integration
Claus Fuglsang - Chief Scientific Officer
Andrew Taylor - Executive Vice President of Food & Beverage Biosolutions
Tina Fanø - Executive Vice President of Planetary Health Biosolutions
...

Read the full article on Seeking Alpha

For further details see:

Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript
Novonesis AS - Class B

NASDAQ: NVZMF

NVZMF Trading

-2.1% G/L:

$56.14 Last:

144 Volume:

$57.342 Open:

mwn-ir Ad 300

NVZMF Latest News

NVZMF Stock Data

$25,118,792,978
414,555,046
N/A
N/A
Chemicals
Materials
DK
Lyngby

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App